January 12, 2012
Torax Medical -- Surgical Procedure Can Help Alleviate Acid Reflux Symptoms
January 09, 2012
Progel Extended Tip Receives FDA Approval
January 09, 2012
Progel Adhesion Barrier Sealant Receives CE Mark
December 14, 2011
Lineagen and Fast Forward Collaborate to Develop Gene and Biomarker-Based Clinical Assays for Multiple Sclerosis
December 13, 2011
Sotera Wireless Completes $12.2 Million Series D Financing, Signs Agreement With Cerner
December 08, 2011
Cylene First-in-Class Agents Show Promise in High Risk Blood Cancers at ASH
November 29, 2011
MD Anderson Study Shows PEM May Indicate If Chemotherapy Is Effective
November 23, 2011
King Fahad Specialist Hospital First to Offer PEM In Middle East
November 14, 2011
Torax Medical Receives CE Mark for the Fenix Continence Restoration System
November 09, 2011
Chimerix to Present at Upcoming Lazard and Piper Jaffray Healthcare Conferences
November 07, 2011
Chimerix Honored with "2011 Southeast Bio Deal of the Year: Venture Capital Transaction" Award
November 07, 2011
InfraReDx Announces TVC Imaging System™ to be Highlighted at TCT 2011
November 07, 2011
InfraReDx Announces the Launch of the TVC Imaging System™ for True Vessel Characterization of Coronary Artery Disease
November 03, 2011
Visit Neomend at the 48th Annual Meeting of The Society of Thoracic Surgeons
October 31, 2011
Pacira Pharmaceuticals, Inc. Announces U.S. FDA Approval of EXPAREL™ For Postsurgical Pain Management
October 27, 2011
Published Data Demonstrates Positron Emission Mammography Has Higher Sensitivity than PET/CT
October 19, 2011
National Institute of Cancer Is the First Center in Mexico to Offer Positron Emission Mammography
October 19, 2011
Gary and Mary West Announce Formation of the West Health Investment Fund, LLC
October 12, 2011
Cylene Advances Breakthrough p53 Activator Toward the Clinic
September 08, 2011
Naviscan Receives CE Mark Approval for High-Resolution Breast PET and PET-Guided Biopsy
Positron Emission Mammography (PEM) Expands into 13 European Countries
August 17, 2011
Altor BioScience Awarded SBIR Phase I Grant by NCI for Research on its Novel IL-15 Super Agonist for Bladder Cancer
August 17, 2011
Guthrie Health First to Offer OTC Products at ScriptCenter® Kiosk
August 09, 2011
ViaCyte Announces Executive Management Changes
August 08, 2011
Chimerix Named by CED as a Top 25 2011 North Carolina Companies To Watch
August 02, 2011
Study Shows Positron Emission Mammography (PEM) May Help Predict Breast Cancer Survival by Identifying Most Aggressive Cancers
July 15, 2011
Medical Device Daily coverage on InfraReDx -
InfraReDx enrolls first patient in CANARY trial
July 08, 2011
Tomophase Receives Notice of the Issuance of Japanese Patent Number 4756218 of its Core Technology
June 28, 2011
Florida Biologix Announces Manufacturing Agreement with Altor BioScience
June 28, 2011
Tomophase Awarded Ninth Patent: Integrated Disease Diagnosis and Treatment System
June 27, 2011
Chimerix and BARDA Reach Agreement Ending GAO Review of Smallpox Antiviral Contract
June 15, 2011
ViaCyte Names Michael Scott Vice President, Device Research & Development
June 14, 2011
Naviscan Further Strengthens Its Board of Directors with The Addition of Dr. Andre Cheng
June 07, 2011
Study Validates Clinical Accuracy of 50% Dose Reduction for Positron Emission Mammography
June 06, 2011
Cylene Presents Encouraging Clinical Data for Oral CK2 Inhibitor at ASCO
June 03, 2011
Miramar firm showcases South Florida's life-science industry
June 02, 2011
NovoStent Announces Appointment of Rick Randall as Chairman of the Board
May 13, 2011
ViaCyte, Inc., Names Anthony Gringeri Chief Development Officer
May 12, 2011
Naviscan Announces Partnership with Chindex Medical Limited for Mainland China, Hong Kong and Macau
May 10, 2011
Naviscan Receives ISO 12485 Quality Management System Certification
May 03, 2011
Naviscan Announces Partnership with TecNologie Avanzate for Italian market
April 27, 2011
UK Acid Reflux Sufferer undergoes new Cutting Edge Procedure
April 20, 2011
InfraReDx Receives European CE Mark Approval of LipiScan™ IVUS Coronary Imaging System
April 13, 2011
Cellular Dynamics Licenses Technolgy from ViaCyte
April 07, 2011
Tomophase Announces First Sale of its OCT Imaging System (OCTIS™ )for Research Use to the University of Texas
April 06, 2011
Study Shows PEM is Easy for Breast Imagers to Learn Regardless of Experience
March 31, 2011
Research on Crucial Role of PET-Guided Biopsy in Initial Breast Cancer Diagnosis & Presurgical Planning Published in the Breast Journal
March 30, 2011
ScriptCenter pharmacy refill kiosk opens
March 28, 2011
Chimerix Appoints Timothy W. Trost Senior Vice President, Chief Financial Officer
March 21, 2011
Can Pharmacy Mistakes Be Solved By Drug ATM? Safeway Installs 2 ATM-Like Drug Dispensing Machines
Spring 2011
Spring 2011 KIOSK EUROPE (page 17)
March 21, 2011
Cephalon Announces Definitive Agreement to Acquire Gemin X
March 15, 2011
Hologic, GE and Naviscan Lead Breast Imaging and Digital Mammography in $2.3 Billion Women's Health Market
March 04, 2011
PEM Helped Surgeon go from Mastectomy to Lumpectomy
March 02, 2011
Navisan Announces European Launch of Ppsitron Emission Mammography
February 24, 2011
Naviscan Announces Collaboration with Neoprobe Corporation to Enable Pipeline Technology Development
February 16, 2011
Altor BioScience Awarded SBIR Phase I Grant by NIAID for HIV Research
February 16, 2011
Company Closes $6 Million Tranche to Support Clinical Development of Novel CRAC Channel Inhibitor
February 16, 2011
Chimerix Awarded BARDA Contract for Advanced Development of CMX001 as Medical Countermeasure Against Smallpox
February 16, 2011
CalciMedica Initiates Phase I Clinical Trial of First CRAC Channel Inhibitor (CCI) for Psoriasis
February 16, 2011
Chimerix Awarded BARDA Contract For Advanced Development Of
Broad Spectrum Antiviral CMX001 As Medical Countermeasure
Against Smallpox
February 16, 2011
BARDA Supports Next Steps for a New Antiviral Drug for Smallpox
February 15, 2011
Joyant-Licensed Technology Earns Broad Patent Protection
February 14, 2011
Chimerix Completes $45 Million Financing to Fund Further Development of Novel Antiviral Therapeutics CMX001 and CMX157
February 09, 2011
Endocyte Annouces Closing of Initial Public Offering & Over-Allotment Option
February 09, 2011
InfraReDx Appoints Donald Southard as President & Chief Executive Officer
February 04, 2011
Endocyte, Inc. Annouces Pricing of Initial Public Offering
February 03, 2011
Pacira Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering
January 31, 2011
Alexion Acquires Taligen Therapeutics and Creates Translational Medicine Group to Accelerate Development of Expanded Portfolio
January 13, 2011
Pacira Pharmaceuticals Presents New Data from EXPAREL Phase 3 Study at Orthopaedic Research Society's 57th Annual Meeting
January 10, 2011
Lineagen Launches FirstStepDx Genetic Testing and Counseling Service to Help Physicians Diagnose Autism and Developmental Delay Earlier
January 10, 2011
ProGEL PLATINUM Surgical Sealant Receives CE Mark - Neomend to Expand into International Markets with Unique Sealant Technology
January 07, 2011
Chimerix Commences CMX001 Open-label Clinical Study for the Treatment of Patients with Life-threatening or Serious dsDNA viral infections